India, June 30 -- Dyne Therapeutics Inc. (DYN) announced the pricing of an underwritten public offering of about 24.24 million shares of its common stock at a public offering price of $8.25 per share.
The company expects gross proceeds from the offering, before deducting underwriting discounts and commissions and offering expenses, to be $200.0 million.
The offering is expected to close on or about July 2, 2025. In addition, Dyne has granted the underwriters a 30-day option to purchase up to an additional 3.64 million shares of its common stock at the public offering price, less the underwriting discounts and commissions.
googletag.cmd.push(function() { googletag.display('div-gpt-ad-1568189509843-0'); });
Morgan Stanley, Jefferies, Stif...